MEDICATION PRIOR AUTHORIZATION REQUEST FORM
FAX this completed form to (866) 399-0929
OR Mail request to: Envolve Pharmacy Solutions PA Dept. | 5 River Park Place East, Suite 210 | Fresno, CA 93720
Call (800) 460-8988 to request a 72-hour supply of medication.
Envolve Pharmacy Solutions will respond via fax or phone within 24 hours of receipt of all necessary information, expect
during weekends and holidays. For immediate response on weekends and holidays, NurseWise will answer your call.
SYNAGIS
®
– All Florida Regions Combined
Coverage Period: Based upon the specific region per the FLDOH website:
http://www.floridahealth.gov/diseases-and-conditions/respiratory-syncytial-virus/
Maximum number of doses: 5
Note: Form must be completed in full. An incomplete form may be returned.
If ≤ 12 months old
Hemodynamically significant cyanotic or acyanotic congenital heart disease on medications to control CHF and will require surgery:
(Specify Diagnosis Code) ______________________
Moderate to severe pulmonary hypertension
If < 12 months old
< 29 completed weeks gestational age at birth (otherwise healthy)
Diagnosis Code: ICD 10: P07.21 – P07.26
Chronic lung disease* (GA < 32 weeks): (Specify Diagnosis Code) _____________________________________
AND: required supplemental oxygen (for at least first 28 days after birth)
*CLD is not asthma, croup, recurrent upper respiratory infections, chronic bronchitis, chronic bronchiolitis, or a history of a previous RSV
infection.
Severe neuromuscular disease
(Specify Diagnosis code) __________________________
Congenital anomalies of the airways
(Specify Diagnosis code) __________________________
Profoundly immunocompromised
(Specify Diagnosis code)__________________________
Cystic Fibrosis with CLD and/or nutritional compromise
Prescriber’s Signature: __________________________________________________________ Date: _____________________________
REQUIRED FOR REVIEW: Copies of medical records (e.g., diagnostic evaluations and recent chart notes), the most recent copies of related
labs, and supporting documentation for clinically appropriate submissions.
The provider must retain copies of all documentation for five years.
NOTE: Pharmacies should not submit separate claims for different dosage strength vials to be administered on the same date.
Only one compound claim submission will be necessary. For example, if the Synagis dosage is 150 mg, the pharmacy should
submit a compound claim that lists the two different strength vials (100 mg and 50 mg).
Weight Criteria for Synagis
®
(palivizumab): (Refer to Weight Change Form)
All weights must be verified for dosing accuracy.
Page 2 of 2